PHARMA MAR, S.A. 22/12/2021 08:28 PHARMA MAR, S.A. On business and financial situation The Company announces the signature of a license and commercialization agreement with Eczacibasi Pharmaceuticals Marketing Co. to commercialize the anticancer drug lurbinectedin in Turkey. Register number: 13305
